Clinical trial
A RanDomized Controlled Trial of the Drug Eluting TEmporary Spur StEnt System vs PERcutaneous Balloon Angioplasty for the TReatment of CriTical Limb Ischemia
NCT06122974 is registered in ClinicalTrials.gov with ReFlow Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A RanDomized Controlled Trial of the Drug Eluting TEmporary Spur StEnt System vs PERcutaneous Balloon Angioplasty for the TReatment of CriTical Limb Ischemia
- Lead sponsor
- ReFlow Medical, Inc.
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 31, 2026
- Completion date
- December 31, 2037
- Enrollment
- 518 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
critical limb ischemia